NCT03677973View on ClinicalTrials.gov

A Study to Investigate the Safety of AB680 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

August 19, 2019

Study Completion Date

August 19, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

AB680

AB680 is a Cluster of Differentiation (CD)73 Inhibitor

OTHER

Placebo

Matching Placebo

Trial Locations (1)

3004

Melbourne, VIC, Melbourne

Sponsors
All Listed Sponsors
lead

Arcus Biosciences, Inc.

INDUSTRY

NCT03677973 - A Study to Investigate the Safety of AB680 in Healthy Volunteers | Biotech Hunter | Biotech Hunter